What buyers miss in home-based healthcare diligence

Most diligence processes in home-based healthcare are financial exercises with a compliance checklist attached. Quality of earnings, payer mix, EBITDA adjustments, licensure review. All necessary. None of it answers the question that determines whether the deal works: will this business still produce these numbers a year after the founder leaves the building?

Census durability is the real asset

A home health or hospice agency's revenue is the sum of its referral relationships, and those relationships often belong to specific people rather than to the company. When one liaison or one administrator holds the top referral accounts personally, the buyer is not acquiring a referral network. It is acquiring an employment negotiation.

Diligence should map referral concentration the way a lender maps customer concentration: which sources produce the census, who owns those relationships, and what happens to each one under new ownership.

The staffing reality behind the schedule

Paper capacity and real capacity are different numbers. An agency can hold a census of 300 on the books while quietly burning out the twelve clinicians who make it possible. Turnover data, contractor reliance, visit-per-clinician trends, and documentation timeliness tell you whether the operation is sustainable or already borrowing against its own staff.

Compliance posture is not a certificate

A clean survey two years ago is not a compliance program. Look at how the organization behaves between surveys: QAPI cadence, documentation audit results, complaint handling, and whether leadership can explain their own compliance data without calling a consultant.

Operators see these things quickly because we have lived the consequences of missing them. That is the argument for putting operational eyes on a deal before the price is set rather than after the surprises surface.